CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- Open-market buys, last 90 days
- $22,023,904
- in 7 filings
- Open-market sales, last 90 days
- $4,490,340
- in 8 filings, $4.5M under 10b5-1 plans
Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −7,925 | $33.04 | $262K | 141,989 |
| 2026-09-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −2,075 | $33.76 | $70K | 139,914 |
| 2026-06-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −1,900 | $40.09 | $76K | 158,014 |
| 2026-06-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −3,792 | $41.39 | $157K | 154,222 |
| 2026-06-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −3,308 | $42.17 | $140K | 150,914 |
| 2026-06-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −1,000 | $43.15 | $43K | 149,914 |
| 2026-03-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −7,161 | $28.04 | $201K | 162,753 |
| 2026-03-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −2,839 | $28.55 | $81K | 159,914 |
| 2026-03-05 | Gault Cheryl Chief Operating Officer | Sale | −2,014 | $28.93 | $58K | 169,914 |
| 2026-02-02 | Gault Cheryl Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +132,000 | 132,000 | ||
| 2025-11-26 | Gault Cheryl Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $1.80 | $9K | 176,928 |
| 2025-11-26 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −5,000 | $30.10 | $150K | 171,928 |
| 2025-11-26 | Gault Cheryl Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 105,407 | ||
| 2025-09-08 | Gault Cheryl Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $1.80 | $9K | 176,928 |
| 2025-09-08 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −5,000 | $38.33 | $192K | 171,928 |
| 2025-09-08 | Gault Cheryl Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 110,407 | ||
| 2025-03-03 | Gault Cheryl Chief Operating Officer | Grant or award | +13,987 | 171,928 | ||
| 2025-02-03 | Gault Cheryl Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +129,000 | 129,000 | ||
| 2024-06-06 | Gault Cheryl Chief Operations Officer | Grant or award · Stock Option (Right to Buy) | +88,442 | 88,442 |
Page 1 of 1 · 19 trades